Impaired mitochondrial function in microvesicular steatosis: Effects of drugs, ethanol, hormones and cytokines

Journal of Hepatology

Volumn 26, Issue SUPPL.2, 1997, Pages 43-53

  Fromenty, Bernard ^a   Pessayre, Dominique ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Drug; Ethanol; Fatty acids; Mitochondria; Steatosis

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ALPHA INTERFERON; AMINEPTINE; AMIODARONE; CYTOKINE; HEXESTROL BIS(2 DIETHYLAMINOETHYL) ETHER; IBUPROFEN; NAPROXEN; PERHEXILINE; PIRPROFEN; SALICYLIC ACID; TETRACYCLINE DERIVATIVE; TIANEPTINE; VALPROIC ACID;

CONFERENCE PAPER; DRUG INDUCED DISEASE; ENZYME ACTIVITY; HEPATITIS; HUMAN; LIPID PEROXIDATION; MITOCHONDRION; PATHOGENESIS; PRIORITY JOURNAL; STEATOSIS;

ANIMALS; COENZYME A; CYTOKINES; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; ETHANOL; FATTY LIVER; HORMONES; HUMANS; METABOLISM, INBORN ERRORS; MITOCHONDRIA, LIVER; OXIDATION-REDUCTION;

EID: 0030917702     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(97)80496-5     Document Type: Article

References (35)

1. Fromenty B, Pessayre D. Inhibition of mitochondrial β-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 1995; 67: 101-54.
2. Pessayre D. Role of reactive metabolites in drug-induced hepatitis. J Hepatol 1995; 23 (Suppl.1): 16-24.
3. Farrell G. Drug-induced Liver Disease. London: ChurchillLivingstone, 1994.
4. Schon EA, Hirano M, DiMauro S. Mitochondrial encephalomyopathies: Clinical and molecular analysis. J Bioenerg Biomembr 1994; 26: 291-9.
5. Latipää PM, Kärki TT, Hiltunen JK, Hassinen IE. Regulation of palmitoylcarnitine oxidation in isolated rat liver mitochondria. Role of the redox state of NAD(H). Biochim Biophys Acta 1986; 875: 293-300.
6. Maddaiah VT. Ammonium inhibition of fatty acid oxidation in rat liver mitochondria. A possible cause of fatty liver in Reye's syndrome and urea cycle defects. Biochem Biophys Res Commun 1985; 127: 565-70.
7. Grimbert S, Fromenty B, Fisch C, Lettéron P, Berson A, Durand-Schneider AM, Feldmann G, Pessayre, D. Decreased mitochondrial oxidation of fatty acids in pregnant mice: Possible relevance to development of acute fatty liver of pregnancy. Hepatology 1993; 17: 628-37.
8. Grimbert S, Fisch C, Deschamps D, Berson A, Fromenty B, Feldmann G, Pessayre D. Effects of female sex hormones on liver mitochondria in non-pregnant female mice: possible role in acute fatty liver of pregnancy. Am J Physiol 1995; 268: G107-G115.
9. Heubi JE, Partin JC, Partin JS, Schubert WK. Reye's syndrome: current concepts. Hepatology 1987; 7: 155-64.
10. Deschamps D, Fisch C, Fromenty B, Berson A, Degott C, Pessayre D. Inhibition by salicylic acid of the activation and thus oxidation of long-chain fatty acids. Possible role in the development of Reye's syndrome. J Pharmacol Exp Ther 1991; 259: 894-904.
11. Fréneaux E, Fromenty B, Berson A, Labbe G, Degott C, Lettéron P, Larrey D, Pessayre D. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial β-oxidation of fatty acids. J Pharmacol Exp Ther 1990; 255: 529-35.
12. Fromenty B, Lettéron R Fisch C, Berson A, Deschamps D, Pessayre D. Evaluation of human blood lymphocytes as a model to study the effects of drugs on human mitochondria. Effects of low concentrations of amiodarone on fatty acid oxidation, ATP levels and cell survival. Biochem Pharmacol 1993; 46: 421-32.
13. Genève J, Hayat-Bonan B, Labbe G, Degott C, Lettéron P, Fréneaux E, Le Dinh T, Larrey D, Pessayre D. Inhibition of mitochondrial β-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug. J Pharmacol Exp Ther 1987; 242: 1133-7.
14. Le Dinh T, Fréneaux E, Labbe G, Lettéron P, Degott C, Genève J, Berson A, Larrey D, Pessayre D. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther 1988; 247: 745-50.
15. Fromenty B, Fréneaux E, Labbe G, Deschamps D, Larrey D, Lettéron R Pessayre, D. Tianeptine, a new tricyclic antidepressant metabolized by β-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice. Biochem Pharmacol 1989; 38: 3743-51.
16. Fréneaux E, Labbe G, Lettéron P, Le Dinh T, Degott C, Genève J, Larrey D, Pessayre, D. Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic. Hepatology 1988; 8: 1056-62.
17. Labbe G, Fromenty B, Fréneaux E, Morzelle V, Lettéron P, Berson A, Pessayre, D. Effects of various tetracycline derivatives on in vitro and in vivo β-oxidation of fatty acids, egress of triglycerides from the liver, accumulation of hepatic triglycerides, and mortality in mice. Biochem Pharmacol 1991; 41: 638-41.
18. Deboyser D, Goethals F, Krack G, Roberfroid M. Investigation into the mechanism of tetracycline-induced steatosis: Study in isolated hepatocytes. Toxicol Appl Pharmacol 1989; 97: 473-9.
19. Kodavanti UP, Mehendale HM. Cationic amphiphilic drugs and phospholipid storage disorder. Pharmacol Rev 1990; 42: 327-54.
20. Guigui B, Perrot S, Berry JR, Fleury-Feith J, Martin N, Métreau JM, Dhumeaux D, Zafrani ES. Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease. Hepatology 1988; 8: 1063-8.
21. Fromenty B, Fisch C, Labbe G, Degott C, Deschamps D, Berson A, Lettéron R Pessayre D. Amiodarone inhibits the mitochondrial β-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther 1990; 255: 1371-6.
22. Fromenty B, Fisch C, Berson A, Lettéron P, Larrey D, Pessayre, D. Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II. J Pharmacol Exp Ther 1990; 255: 1377-84.
23. Deschamps D, De Beco V, Fisch C, Fromenty B, Guillouzo A, Pessayre D. Inhibition by perhexiline of oxidative phosphorylation and the β-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions. Hepatology 1994; 19: 948-61.
24. Krähenbühl S, Talos C, Reichen J. Mechanisms of impaired hepatic fatty acid metabolism in rats with long-term bile duct ligation. Hepatology 1994; 19: 1272-81.
25. Kukielka E, Dicker E, Cederbaum AI. Increased production of reactive oxygen species by rat liver mitochondria after chronic ethanol treatment. Arch Biochem Biophys 1994; 309: 377-86.
26. Fromenty B, Grimbert S, Mansouri A, Beaugrand M, Erlinger S, Rötig A, Pessayre D. Hepatic mitochondrial DNA deletion in alcoholics. Association with microvesicular steatosis. Gastroenterology 1995; 108: 193-200.
27. Mitsuya H, Jarrett RF, Matsukura M, Veronese FDM, DeVico AL, Sarngadharan MG, Johns DG, Reitz MS, Broder S. Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2′,3′-dideoxynucleosides in vitro. Proc Natl Acad Sci USA 1987; 84: 2033-7.
28. Simpson MV, Chin CD, Keilbaugh SA, Lin TS, Prusoff WH. Studies on the inhibition of mitochondrial DNA replication by 3'-azido-3'-deoxythymidine and other dideoxynucleoside analogs which inhibits HIV-1 replication. Biochem Pharmacol 1989; 38: 1033-6.
29. Lai KK, Gang DL, Zawacki JK, Cooley TP. Fulminant hepatic failure associated with 2′,3′-dideoxyinosine (ddI). Ann Intern Med 1991; 115: 283-4.
30. Zoulim F, Trépo C. Nucleoside analogs in the treatment of chronic viral hepatitis. Efficiency and complications. J Hepatol 1994; 21: 142-4.
31. Richardson FC, Engelhardt JA, Bowsher RR. Fialuridine accumulates in DNA of dogs, monkeys and rats following longterm oral administration. Proc Natl Acad Sci USA 1994; 91: 12003-7.
32. Bellringer ME, Rahman K, Coleman R. Sodium valproate inhibits movement of secretory vesicles in rat hepatocytes. Biochem J 1988; 249: 513-9.
33. Lettéron P, Fromenty B, Terris B, Degott C, Pessayre D. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol 1996; 24: 200-8.
34. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Rad Biol Med 1991; 11: 81-128.
35. Zatloukal K, Böck G, Rainer I, Denk H, Weber H. High molecular weight components are main constituents of MaIlory bodies isolated with a fluorescence activated cell sorter. Lab Invest 1991; 64: 200-6.